Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -1,560 | -1,472 | -6,326 | -750 |
| Depreciation Amortization | 1,207 | 979 | 485 | 4 |
| Accounts receivable | -6 | -5 | N/A | N/A |
| Accounts payable and accrued liabilities | 355 | 17 | N/A | 68 |
| Other Working Capital | 666 | 157 | 633 | 380 |
| Other Operating Activity | -1,671 | -310 | 3,159 | -1,099 |
| Operating Cash Flow | $-1,010 | $-634 | $-2,049 | $-1,397 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 540 | N/A | N/A | 1,557 |
| Common Stock Issued | N/A | 475 | N/A | N/A |
| Other Financing Activity | -676 | -174 | 3,327 | 0 |
| Financing Cash Flow | $-136 | $301 | $3,327 | $1,557 |
| Beginning Cash Position | 1,361 | 1,361 | 83 | 83 |
| End Cash Position | 214 | 1,028 | 1,361 | 244 |
| Net Cash Flow | $-1,146 | $-333 | $1,278 | $161 |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,010 | -634 | -2,049 | -1,397 |
| Free Cash Flow | -1,010 | -634 | -2,049 | -1,397 |